Is the price fair?
What LIN's price assumes
Linde plc trades at 31.7× earnings against 28.3× for the median Specialty Chemicals name, more expensive than its own group.
31.7
Trailing P/E · Specialty Chemicals median 28.3 · 1.12× the median: the market pays up for this one
- Price / sales
- 6.65
Price / sales · as of 2026-Q1
- Free cash flow yield
- 2.1%
Free cash flow yield · Specialty Chemicals median 3.9%
- Growth the price implies
- +17%
Growth the price implies · The price pays for +17% free cash flow growth a year for a decade; the business has delivered −2.7% a year over the last three.
Details›
- Price / book2026-Q1
- 5.98
- EV / EBIT2026-Q1
- 27.0
- EV / sales2026-Q1
- 7.16
- Basic Materials median P/E153 names
- 22.8
- Specialty Chemicals median P/E37 names
- 28.3
- Free cash flow, trailing twelve months
- $4.97B
- Market capitalisation
- $236.8B
- 3-year revenue growth
- +2.3%
- 3-year free cash flow growth
- −2.7%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $490.43 |
| Its own P/E history, median | $515.34 |
| Its own P/E history, upper quartile | $620.14 |
| 52-week range | $386.85 – $529.65 |
| Today | $490.44 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Specialty Chemicals
Ranks #10 of 36 by Smart Score